Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer
There is an unmet need to improve the response to immune checkpoint blockade in patients with head and neck squamous cell carcinoma (HNSCC). Here the authors show that aberrant HER3 activation sustains the proliferation of PIK3CA wild type HNSCC cells and that HER3 inhibition increases response to P...
Full description
Bibliographic Details
Main Authors: |
Zhiyong Wang,
Yusuke Goto,
Michael M. Allevato,
Victoria H. Wu,
Robert Saddawi-Konefka,
Mara Gilardi,
Diego Alvarado,
Bryan S. Yung,
Aoife O’Farrell,
Alfredo A. Molinolo,
Umamaheswar Duvvuri,
Jennifer R. Grandis,
Joseph A. Califano,
Ezra E. W. Cohen,
J. Silvio Gutkind |
Format: | Article
|
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Nature Communications
|
Online Access: | https://doi.org/10.1038/s41467-021-22619-w
|